These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 3976438
1. Prevention of recurrent life-threatening ventricular arrhythmias by temporary cardiac pacing. Pekarsky V, Gimrikh E, Karpov R, Popov S, Chekhov A, Savenkov G, Pekarskaya M. Acta Med Scand; 1985; 217(1):95-9. PubMed ID: 3976438 [Abstract] [Full Text] [Related]
2. [Value and methods of temporary stimulation of the heart to prevent dangerous arrhythmias]. Pekarskiĭ VV, Gimrikh EO, Zelenov VM, Popov SV. Kardiologiia; 1984 May; 24(5):13-7. PubMed ID: 6205211 [Abstract] [Full Text] [Related]
3. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN. Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357 [Abstract] [Full Text] [Related]
4. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence. Heidbüchel H, Tack J, Vanneste L, Ballet A, Ector H, Van de Werf F. Circulation; 1994 Mar 01; 89(3):1051-9. PubMed ID: 8124790 [Abstract] [Full Text] [Related]
6. The influence of concomitant drug therapy on the efficacy of atrial overdrive stimulation for prevention of atrial tachyarrhythmias. Konz KH, Danilovic D, Brachmann J, Attuel P, el Allaf D, John C, Malinowski K, Le Blanc U, Szendey I, Schibgilla V, Motzke T. Pacing Clin Electrophysiol; 2003 Jan 01; 26(1P2):272-7. PubMed ID: 12687827 [Abstract] [Full Text] [Related]
8. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Rees SA, Curtis MJ. Circulation; 1993 Jun 01; 87(6):1979-89. PubMed ID: 8504513 [Abstract] [Full Text] [Related]
9. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy. Mason JW, Swerdlow CD, Winkle RA, Griffin JC, Ross DL, Keefe DL, Clusin WT. Am Heart J; 1982 Apr 01; 103(4 Pt 2):633-9. PubMed ID: 7064805 [Abstract] [Full Text] [Related]
10. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ, Prystowsky EN, Zipes DP. Am Heart J; 1983 Oct 01; 106(4 Pt 2):887-94. PubMed ID: 6613835 [Abstract] [Full Text] [Related]
11. The use of pacemaking for the treatment of acute arrhythmias. 2. Preston TA. Heart Lung; 1977 Oct 01; 6(2):249-55. PubMed ID: 584714 [Abstract] [Full Text] [Related]
12. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. Brugada P, Green M, Abdollah H, Wellens HJ. Circulation; 1984 Jan 01; 69(1):87-92. PubMed ID: 6689650 [Abstract] [Full Text] [Related]
13. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease. Ragonese P, Drago F, Guccione P, Santilli A, Silvetti MS, Agostino DA. Pacing Clin Electrophysiol; 1997 Dec 01; 20(12 Pt 1):2917-23. PubMed ID: 9455751 [Abstract] [Full Text] [Related]
14. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents. Kudenchuk PJ, Kron J, Walance C, McAnulty JH. Am J Cardiol; 1990 Feb 15; 65(7):446-52. PubMed ID: 2305683 [Abstract] [Full Text] [Related]
15. [Value and risk of programmed ventricular stimulation in patients with chronic recurrent ventricular tachycardia (author's transl)]. Steinbeck G, Manz M, Lüderitz B. Klin Wochenschr; 1981 Feb 02; 59(3):111-21. PubMed ID: 7206600 [Abstract] [Full Text] [Related]
16. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD. J Cardiovasc Electrophysiol; 2012 Mar 02; 23(3):296-301. PubMed ID: 21955243 [Abstract] [Full Text] [Related]
17. Treatment of life-threatening ventricular arrhythmias by a combination of antiarrhythmic drugs and right ventricular pacing. Ector H, Van Brabandt H, De Geest H. Pacing Clin Electrophysiol; 1984 Jul 02; 7(4):622-7. PubMed ID: 6205361 [Abstract] [Full Text] [Related]
18. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig. Tuininga YS, De Langen CD, Crijns HJ, Wiesfeld AC, Mook PH, Bel KJ, Lie KI. Pacing Clin Electrophysiol; 1996 May 02; 19(5):802-10. PubMed ID: 8734747 [Abstract] [Full Text] [Related]
19. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action. Curtis MJ, Barsby RW, Forster R. J Cardiovasc Pharmacol; 1995 Apr 02; 25(4):643-51. PubMed ID: 7596134 [Abstract] [Full Text] [Related]
20. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents. Nademanee K, Singh BN. Am J Cardiol; 1990 Jan 02; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]